Aberrant cytoplasmic localization of nucleophosmin in primary acute myeloid leukemia has been implicated in disrupting ARF-MDM2-p53 signal pathway and contributed to leukemogenesis [39,40]. The gene discussed is CDKN2A; the disease is acute myeloid leukemia.